Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up

This study provides Class II evidence that for patients with acute optic neuritis, EPO as an adjunct to methylprednisolone is well tolerated and does not improve long-term visual outcomes. Trial Registration Information The trial was preregistered before commencement at clinicaltrials.gov (NCT01962571).

http://nn.neurology.org/cgi/content/short/10/4/e200067?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - April 24, 2023 Category: Neurology Authors: Küchlin, S., Ihorst, G., Grotejohann, B., Beisse, F., Heinrich, S. P., Albrecht, P., Ungewiss, J., Wörner, M., Hug, M. J., Wolf, S., Diem, R., Lagreze, W. A., for the TONE Study Group Tags: All Clinical trials, Multiple sclerosis, Optic neuritis; see Neuro-ophthalmology/Optic Nerve Research Article Source Type: research